In vivo antitumor and immunomodulation activities of different molecular weight Lambda-Carrageenans from Chondrus ocellatus

被引:256
作者
Zhou, GF
Sun, YP
Xin, H
Zhang, YN
Li, Z
Xu, ZH [1 ]
机构
[1] Acad Sinica, Inst Oceanol, Qingdao 266071, Peoples R China
[2] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China
[3] Coll LaiYang Agr, Qingdao 266109, Peoples R China
关键词
microwave degradation; molecular weight; lambda-carrageenan; anti-tumor; immunomodulation;
D O I
10.1016/j.phrs.2003.12.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
lambda-Carrageenan is a sulfated galactan isolated from some red algae and have been reported to have many kinds of biological activities. lambda-Carrageenan from Chondrus ocellatus, an important economic alga in China and many other parts of the world, was degraded by microwave, and obtained five products that have different molecular weight: 650, 240, 140, 15, 9.3 kDa. Analytical results confirmed that microwave degradation might not change the chemical components and structure of polysaccharides under certain condition. In this study, tumor-inhibiting activities, weight of immune organ, nature killer cells activity, lymphocyte proliferation ratio and pathological slice of spleen and tumor cells from the control group and lambda-carrageenan-treated mice of transplanted S 180 and H22 tumor were investigated. The results indicated that the five lambda-carrageenan samples all showed antitumor and immunomodulation activities in different degree. Molecular weight of polysaccharides had notable effect on the activities. In addition, their antitumor and immunomodulation have some relevance and the five lambda-carrageenans probably inhibited tumor by means of activating the immunocompetence of the body. Among all the experiment results, samples with the highest activities are PC4 and PC5 whose molecular weight are 15 and 9.3 kDa. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:47 / 53
页数:7
相关论文
共 27 条
[1]  
ADACHI T, 2001, INT J BIOL MACROMOL, V28, P395
[2]   ANTICOAGULANT ACTIVITY OF CARRAGEENAN [J].
ANDERSON, W ;
DUNCAN, JGC .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1965, 17 (10) :647-&
[3]   ASCOT: a comprehensive clinical database for gastro-oesophageal cancer surgery [J].
Cummins, J ;
McCulloch, P .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2001, 27 (08) :709-713
[4]   Exocellular polysaccharides from cyanobacteria and their possible applications [J].
De Philippis, R ;
Vincenzini, M .
FEMS MICROBIOLOGY REVIEWS, 1998, 22 (03) :151-175
[5]   COLORIMETRIC METHOD FOR DETERMINATION OF SUGARS AND RELATED SUBSTANCES [J].
DUBOIS, M ;
GILLES, KA ;
HAMILTON, JK ;
REBERS, PA ;
SMITH, F .
ANALYTICAL CHEMISTRY, 1956, 28 (03) :350-356
[6]   POLYSACCHARIDES IN PHARMACY - CURRENT APPLICATIONS AND FUTURE CONCEPTS [J].
FRANZ, G .
PLANTA MEDICA, 1989, (06) :493-497
[7]   Structure-activity relationship of antithrombotic polysaccharide derivatives [J].
Franz, G ;
Alban, S .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1995, 17 (06) :311-314
[8]   ANTICOAGULANT, FIBRINOLYTIC AND ANTIAGGREGANT ACTIVITY OF CARRAGEENANS AND ALGINIC ACID [J].
GUVEN, KC ;
OZSOY, Y ;
ULUTIN, ON .
BOTANICA MARINA, 1991, 34 (05) :429-432
[9]   Acid hydrolysis of κ- and l-carrageenan in the disordered and ordered conformations:: Characterization of partially hydrolyzed samples and single-stranded oligomers released from the ordered structures [J].
Hjerde, T ;
Smidsrod, O ;
Stokke, BT ;
Christensen, BE .
MACROMOLECULES, 1998, 31 (06) :1842-1851
[10]  
ISHIZAKA S, 1980, J IMMUNOL, V125, P2232